Symbiotics
Salvador Vidal currently serves as the Head of Sales and Business Development at Symbiotics, starting in April 2023, specializing in market access for impact investing in emerging economies. Prior experience includes leadership roles at Edmond de Rothschild and BNP Paribas Wealth Management, where responsibilities encompassed enhancing client experience, managing sales strategies across multiple regions, defining KPIs, and implementing innovative solutions in wealth management. Salvador's career began at UBS AG, focusing on market development and client management. Educational qualifications include a Master's degree in International Relations and a Licences in International Economics and Financial Law, both obtained from the University of Geneva.
Symbiotics
Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 7,300 investments representing more than USD 9.2 billion for 570 companies in 95 countries. We manage an aggregate portfolio of USD 2.9 billion spread across 23 funds and mandates. Our portfolio companies have also benefited from over 145 technical assistance projects worth more than USD 18 million.